|
Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho
|
|
0
|
463
|
August 2, 2023
|
|
Diagnostics to support the scaling up of shorter, safer tuberculosis regimens
|
|
0
|
463
|
August 1, 2023
|
|
Public consultation for the Target Product Profile TB diagnostic tests for peripheral settings
|
|
0
|
582
|
July 31, 2023
|
|
WHO issues rapid communication on use of targeted next-generation sequencing for diagnosis of drug-resistant tuberculosis
|
|
1
|
551
|
July 29, 2023
|
|
Advanced TB Research Training Course
|
|
0
|
530
|
July 26, 2023
|
|
Diagnostic accuracy of three computer-aided detection systems for detecting pulmonary tuberculosis on chest radiography when used for screening
|
|
0
|
482
|
July 14, 2023
|
|
Webinar on Increasing Access to Molecular Diagnostics: TrueNAT
|
|
0
|
401
|
June 23, 2023
|
|
Online community of practice on tuberculosis with nearly 2500 members
|
|
0
|
275
|
June 21, 2023
|
|
Smear microscopy needs to be replaced with molecular testing for tuberculosis
|
|
0
|
283
|
June 16, 2023
|
|
Upending the model of AI adoption
|
|
0
|
436
|
June 8, 2023
|
|
Achieving universal access to rapid tuberculosis diagnostics
|
|
0
|
330
|
May 26, 2023
|
|
TB testing stuck in the previous century, and waiting for change
|
|
0
|
407
|
May 19, 2023
|
|
Rapid TB Diagnostics: Relevance to Private Health Sector
|
|
0
|
335
|
May 18, 2023
|
|
Transforming tuberculosis diagnosis
|
|
0
|
440
|
May 1, 2023
|
|
WHO releases first-ever Standard on universal access to rapid TB diagnostics
|
|
0
|
305
|
April 19, 2023
|
|
Integrating tuberculosis and COVID-19 molecular testing
|
|
0
|
394
|
April 14, 2023
|
|
Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing
|
|
0
|
334
|
April 1, 2023
|
|
India is well placed to scale innovations in tuberculosis diagnostics
|
|
0
|
305
|
March 28, 2023
|
|
Local startups are harnessing AI and new tech to take on TB
|
|
0
|
348
|
March 27, 2023
|
|
Fast-tracking progress to End TB: high-level opportunities for investment and action
|
|
0
|
281
|
March 21, 2023
|
|
Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis
|
|
0
|
366
|
March 13, 2023
|
|
Free eBook on Quality of Tuberculosis Care
|
|
0
|
311
|
March 12, 2023
|
|
Global Fund, USAID and Stop TB Partnership's New Collaboration With Molbio Diagnostics Will Increase Access to Rapid Molecular Tests for TB
|
|
0
|
289
|
March 10, 2023
|
|
Early user experience and lessons learned using ultra-portable digital X-ray with computer-aided detection (DXR-CAD) products: A qualitative study from the perspective of healthcare providers
|
|
0
|
317
|
March 3, 2023
|
|
Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring
|
|
0
|
320
|
March 2, 2023
|
|
Job Opportunity: Tech Scout, Associate
|
|
0
|
366
|
February 1, 2023
|
|
Funding Opportunity for Molecular TB Assay Developers
|
|
0
|
374
|
February 1, 2023
|
|
Development of Swab-Based TB Assays on Point-of-Care Molecular Platform
|
|
0
|
173
|
January 31, 2023
|
|
The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes
|
|
0
|
467
|
January 26, 2023
|
|
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
|
|
0
|
330
|
January 20, 2023
|